Laura Gallagher

I gained knowledge of the stages post preclinical development, points of interaction with regulatory agencies, when processes should be fixed in CMC and non-clinical. The trainers were very knowledgeable, experienced and enthusiastic which helped create a positive learning environment. The course was a great learning opportunity for myself and I would recommend it to other programme managers working in preclinical research to be aware of what the steps or research programmes entail and regulatory affairs and process to consider.